Pathogenesis of multiple sclerosis.
Ffrench-Constant
C
C
Wellcome/CRC Institute of Developmental Biology and Cancer, Cambridge.
D000818:Animals; D000917:Antibody Formation; D001327:Autoimmune Diseases / Q000209:etiology / Q000235:genetics / Q000276:immunology* / Q000473:pathology / Q000628:therapy; D001812:Blood-Brain Barrier / Q000276:immunology; D015496:CD4-Positive T-Lymphocytes / Q000276:immunology*; D004195:Disease Models, Animal; D006683:HLA-DQ Antigens / Q000235:genetics / Q000276:immunology; D006684:HLA-DR Antigens / Q000235:genetics / Q000276:immunology; D059810:HLA-DR Serological Subtypes; D006801:Humans; D008967:Molecular Biology / Q000379:methods; D009103:Multiple Sclerosis / Q000209:etiology / Q000235:genetics / Q000276:immunology* / Q000473:pathology / Q000628:therapy; D009836:Oligodendroglia; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology
D006683:HLA-DQ Antigens; C063831:HLA-DQ6 antigen; D006684:HLA-DR Antigens; D059810:HLA-DR Serological Subtypes; C106559:HLA-DR15 antigen